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Abstract 
Cobalt-chromium-molybdenum (CoCrMo) alloy-based metal-on-metal prostheses have been the 
implant of choice for total hip replacement in younger patients. However 6.2% of patients 
require revision of their CoCrMo total hip replacement (THR) implant within five years of 
surgery and their use was restricted in 2013. We aimed to determine if there were individual 
differences in the immune response to wear debris that might indicate a poor outcome with a 
CoCrMo prosthesis.  
Blood from 22 donors was incubated with CoCrMo particles (>99.9% less than 10µm diameter) 
generated by a wear simulator for 24h. T cell phenotype was assessed by immunostaining and 
secretion of 8 different pro- and anti-inflammatory cytokines was measured using multiplex 
technology. Clear differences were seen between individuals in the induction of Th17 and Th1 
responses, with some donors showing pro-inflammatory responses (increased IL17 or IFNγ) and 
others showing anti-inflammatory responses (decreased IL17 or IFNγ). The only differences 
seen for gender and age related to increased IL-10 expression from T cells in females (p=0.008) 
and a trend towards decreased IL-6 expression systemically for older donors (p=0.058). 
We conclude that individuals show differential responses to CoCrMo wear debris and that these 
responses could give early indications of the suitability of the patient for a metal-on-metal 
prosthesis. 
 
Keywords: Metal-on-metal, total hip replacement, osteoarthritis, wear particles, wear particle 
characterisation  
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Introduction 
The number of total hip replacement (THR) operations carried out in the UK in 2011 reached 
80,314 (National Joint Registry of England and Wales, 9th Report 2012). It is expected that by 
2030 this number will increase by 170% (1, 2) due to an ageing and increasingly obese population 
who are more at risk of developing osteoarthritis (OA)(1, 3). Currently, the most effective 
treatment for patients presenting with hip OA is THR surgery.  
Surgery is carried out with varying rates of success dependent on several factors, including the 
choice of prosthesis, with some  prosthesis lasting for only 5-7 years (1). Cobalt-chromium-
molybdenum (CoCrMo) alloy-based metal-on-metal THR prostheses have been shown to have a 
50% greater risk of failure two years post-primary surgery compared to metal-on-polyethylene or 
ceramic-on-ceramic THR (1). Recent clinical observations have shown that 6.2% of patients 
have an adverse reaction to their CoCrMo THR implant within the first two years after THR (1) 
and as a result the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK 
issued guidelines on the use of these implants which has resulted in a number of NHS Trusts 
placing restrictions on their use..  
However, it should be noted that the issues of early implant failure and wear with CoCrMo THR 
and CoCrMo Hip Resurfacing differ in their origin. Taper junction wear and misplacement of 
the joint are major contributors to failure in THR (4, 5) whereas poor design of the implant has 
been implicated with early failure in hip resurfacing (6). Certain designs of CoCrMo hip 
resurfacing have been shown to have excellent survivorship and have the additional benefit of 
preserving femoral bone and reducing the risk of dislocation. Therefore the ability to return to 
the use of some well designed CoCrMo hip resurfacing might enable patient to benefit from it’s 
unique advantages. 
The major factors contributing to the requirement for revision surgery in patients with CoCrMo 
implants are pain and aseptic joint loosening (7). As nano-scale wear debris is generated, it can 
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enter the peri-joint tissue leading to tissue necrosis and induce general inflammation (8-12) and it 
has been postulated that it is this combination of tissue damage and inflammation, which causes 
aseptic loosening. There is also the potential for torque to be a factor in loosening if the joint is 
not sufficiently lubricated by entrained fluid from around the joint (13). 
Instances of aseptic loosening of the joint in patients with metal-on-metal prostheses are greater 
than with any other material combination (1) and there is evidence that wear particles from 
cobalt chromium metal-on-metal prostheses are contributing to joint failure. The size and shape 
of the wear particles generated are varied and are generally in the range of 0.1-100µm in 
diameter. It is thought that particles which are in the region of 10µm in diameter are of most 
immunological relevance as they are of a size which is readily ingested by phagocytic immune 
cells, primarily macrophages (10, 12, 14). In support of this, wear debris of different sizes were 
shown to elicit different immune responses with respect to increased inflammatory marker 
secretion from macrophages (9, 15) with debris ~5-10µm the most bioreactive. Furthermore, 
metal wear debris become coated in protein from intra-tissue fluids and serum and it is 
postulated that this coating, which would include immunomodulatory proteins such as 
complement, could be used by macrophages to recognise and internalise non-biological materials 
(14). 
Beyond the role of macrophages, the mechanisms of how the immune system reacts to such 
wear particles and the degree of individual variability in the response are unknown. In particular 
immune function alters with age (16-19) and gender (20, 21) and thus the immune response to 
orthopaedic wear debris is also likely to differ between young and old patients and males and 
females. Understanding how different age and gender groups respond to debris is important if 
we are to stratify patients and provide the most suitable implant for specific patients. 
This study aimed to characterise the size and size distribution of particulate wear debris and 
determine the impact of particulate wear debris on the immune system with particular reference 
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to T lymphocytes and the plasma cytokine/chemokine repertoire. There is potential for such 
characterisations to be used to form the basis of prognostic testing to determine the suitability of 
a patient to be able to benefit from the unique advantages that CoCrMo hip resurfacing 
provides. 
Materials and Methods 
Participants 
Healthy volunteers aged between 21 and 80, with no known inflammatory diseases and no recent 
infections, took part in the study. All volunteers gave written informed consent and ethical 
approval for the study was received from the University of Birmingham’s Ethical Review 
Committee (ref: ERN_12-1184).  
Wear Debris 
Generation 
CoCrMo wear debris were a kind gift from Smith & Nephew (Warwick, UK). Debris was 
generated using a proprietary wear simulator following 2.5x105 cycles on the simulator under 
adverse conditions (subluxation) and was collected in heat inactivated fetal calf serum (FCS). 
Debris was isolated from FCS by centrifugation at 80,000xg for 30 minutes. Debris was then 
resuspended in phosphate buffered saline (PBS) and sterilised with 100U/ml penicillin and 
100µg/ml streptomycin for 24 hours. Sterility was confirmed through incubation of debris on an 
antibiotic-free agar plate for 24 hours at 37oC. 
Characterisation 
Particle size analysis was performed using a laser diffraction based Mastersizer 2000 (Malvern 
Instruments, Malvern, UK) with an automated liquid sample homogeniser and feed system. The 
system was flushed three times with fresh PBS (no particles) filtered beforehand with 0.22μm 
pore size syringe filter (Millipore) to remove potential contaminants in the size range of interest. 
6 
 
The particle-PBS solution was added to the sample feeder 1mL at a time and diluted when 
necessary to obtain a laser obscuration value of 3-5%, which was found to produce the most 
reliable measurements. The system was then flushed again with PBS before adding the final 
particle-PBS sample for analysis. The measurement integration time was 1 second with 10 repeat 
measurements performed on each sample. Wear debris was imaged using a Zeiss EVO MA19 
scanning electron microscope (Carl Zeiss Ltd., UK). 
Blood Samples 
Peripheral venous blood, which contains on average 1x106 peripheral blood mononuclear cells 
(PBMCs) was collected in to heparinised Vacutainer™ tubes (BD Bioscience). The blood was 
aliquoted into two separate bijoux tubes and CoCrMo wear debris at a concentration of 20 
particles/PBMC were added to one tube as previously described (22) and the second was left 
unchallenged but included 10% FCS to account for any FCS protein forming the protein corona 
around the wear debris. HEPES (5% v/v) was added to buffer the blood to prevent coagulation 
and haemolysis. All tubes were incubated on a rotator at 37oC, 5% CO2 for 24 hours. 
T Cell and Cytokine Analysis 
PBMC Isolation 
PBMCs were isolated from whole blood by density gradient centrifugation using Ficoll-paque 
(GE Healthcare). Briefly, whole blood was layered onto Ficoll-paque and centrifuged at 400xg 
for 30 minutes. The buffy coat was aspirated and washed twice with PBS and the PBMCs were 
counted using a CASY® Cell Counter (Roche). Plasma was also aspirated, aliquoted and frozen 
until required for cytokine analysis. 
T cell phenotype and cytokine secretion 
T cell populations and cytokine secretion were analysed by immunostaining and flow cytometry 
using fluorochrome conjugated antibodies to CD3 (APC-Cy7), CD4 (FITC or Pacific Blue), 
CD25 (APC), CD45RA (APC), CCR7 (FITC), FoxP3 (PE), IL-10 (APC), IL-17 (PE), and IFNγ 
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(APC) to identify Tregs, T helper cell memory cell subsets, Th1, Th17, and plastic Th1 
populations (IFNγ+IL-17+). All antibodies were from eBioscience and fluorescence staining was 
detected and analysed using a CyAn ADP flow cytometer (Beckton Dickinson) and analysed 
using GraphPad Prism 5 software. 
Cytokine analysis 
IL-1β, IL-6, IL-10, IL-13, GM-CSF and TNFα were measured in plasma taken from CoCrMo 
treated whole blood using a Bio-Plex Luminex assay (Bio-Rad). All plasma samples were diluted 
in accordance with the manufacturer’s recommendations. 
Statistical Analysis 
SPSS® Statistics 20 (IBM®, UK) was used for the statistical analyses of raw data. The normality 
of the distribution of the data was assessed using the Sharpiro-Wilk test as N < 50; p > 0.05 
indicated normality. An independent or paired T-test was applied - with natural log 
transformation if necessary - for normally distributed data, whilst Mann Whitney U or Wilcoxson 
Rank Sum test were used for unpaired and paired non-parametric data, respectively. P<0.05 was 
deemed statistically significant. 
Results 
Subject Demographics 
22 subjects were recruited and split into two age groups with the ‘young’ group consisting of 
subjects aged 20-35 whilst the ‘old’ group consisted of subjects aged 45-65. 75% of subjects were 
in the young category. Gender was split reasonably evenly with 55% of subjects being female 
(Table 1). 
Wear particle characterisation 
Figure 1a shows the particle size distribution, in terms of total volume and number, of particle 
wear samples obtained directly from the wear simulator (‘stock solution’) and after isolating the 
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particles of interest (up to 10μm) from that stock solution. The contribution of sub-micron and 
micron (up to 10μm) are quantified in Table 2. In the stock sample, particle sizes between 10-
200μm accounted for approximately 54% of the total volume (and, by extension, total mass) of 
the wear particles with a volume-weighted mean size of 27μm. However, the number% 
distribution data showed that this size range represented just 0.02% of the total number of 
particles, with those below 10μm by far the most prevalent in number (>99%) (Figure 1b). 
Scanning electron microscopy (SEM) images of the sample confirmed the prevalence of these 
sub-micron particles and revealed their highly rounded morphology (Figure 2a, b). The majority 
of the micron scale particles were found to be between 1-3 μm in size in both the particle sizing 
data (by number) and from analysis of the SEM images. In the fraction of debris isolated after 
centrifugation, the upper size limit of the wear particles was 60μm (Figure 1a), but close 
examination of the data revealed that wear-particles above 10μm in size contributed only 0.01% 
to the total number of particles in the sample (figure 1b). The number-percent distribution of the 
isolated fraction was still found to cover the 1-10μm range and hence the procedure successfully 
isolated the wear-particles of interest from the FCS solution. 
Effect of wear debris on T cell populations 
Hallab et al (2012) showed that T cells are activated as a result of increased wear debris and metal 
ions, but phenotypic and cytokine expression changes have not been characterised. To address 
this PBMCs from healthy donors were challenged with CoCrMo wear debris or 10% FCS for 24 
hours. Immunostaining and flow cytometry data were analysed accounting for changes in 
CD3+CD4+ T cell phenotypes within the control (PBS) and wear debris (CoCrMo) groups. No 
significant differences between the control and CoCrMo groups were found with regard to T cell 
phenotype or T cell cytokine expression (Figure 3). However, differences between the control 
and CoCrMo treated cells became apparent once individual donor responses to debris challenge 
were analysed (Figure 4). The two cell populations showing the differential response between 
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subjects were the two pro-inflammatory cell types Th17 and Th1, with the most marked 
differences for Th17. For Th17 there was a clear split in the volunteer responses, with subjects 
either giving a clear pro-inflammatory response, increasing their IL17 expression, or an anti-
inflammatory response with decreased IL-17 (Figure 4). For Th1, there was an even split in the 
population with 6 subjects displaying decreased numbers of Th1 cells (measured by reduced 
IFNγ expression in the CD4+ population) and 6 subjects displaying an increase in the prevalence 
of Th1 cells.  
Cytokine analysis 
Plasma samples from each subject were analysed using a Bio-Plex Luminex cytokine panel to 
determine the total cytokine response to CoCrMo challenge, regardless of originating cell type. 
There was a very clear response to CoCrMo debris with 5 cytokines significantly elevated above 
baseline following CoCrMo challenge, with little individual variability (Figure 5). 
Gender and age impact on immune response to wear debris 
Data from the National Joint Registry of England and Wales shows greater incidence of aseptic 
loosening of CoCrMo hip implants in females compared to males (1). The reasons for this are 
unclear and therefore the possibility of an altered immune response to wear debris in women 
was investigated. Of all of the cytokines and T cell populations analysed, CD4+IL-10+ T cells 
were the only population found to differ with gender, with these anti-inflammatory cells 
significantly increased in female subjects following CoCrMo challenge (Figure 6a).  
Hip replacements are more frequent in the elderly. The immune system changes with age and 
thus the response to pathogens or other foreign objects differs as we get older. Therefore, it was 
important to assess whether the immune response to CoCrMo wear debris also altered with age. 
We found a trend towards increased serum IL-6 in younger subjects compared with older 
subjects following CoCrMo challenge (Figure 6b), in line with previous reports of 
immunosenescence and reduced inflammatory response to challenge in older people (23, 24). 
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No significant differences could be found for other cytokines or T cell populations when 
comparing young vs old or male vs female subjects. 
Discussion 
Much attention has been focussed on the failure of CoCrMo bearings used in THR surgery in 
recent years (25-28). Aseptic loosening and subsequent joint failure is accompanied with peri-
joint tissue necrosis and osteolysis leading to pain and reduced mobility for 6.2% of CoCrMo 
THR patients (1). However, for the remaining 85% of patients, these prostheses cause no 
unwanted pathology and have a longevity which matches and in some cases, surpasses that of 
other bearing types. Well designed CoCrMo hip resurfacing implants have shown excellent 
survivorship in certain groups with survivorship of 99.4% at 15 years in patients under 50 years 
of age with osteoarthritis (29). These devices have the added advantages of preservation of the 
femoral bone and a reduced rate of dislocation. However, due to the concern over the use of 
CoCrMo their use has declined. 
In this study we aimed to determine whether there was a profile of inflammatory markers in 
blood from healthy donors challenged with CoCrMo wear debris, which would indicate a 
potentially adverse inflammatory response which could lead to accelerated bearing failure and 
aseptic loosening. We found that T cell populations and serum-derived cytokine expression 
differed greatly between each subject. Different combinations of pro- and anti-inflammatory 
cytokines were present following CoCrMo challenge in different subjects, with the Th17 cell 
response showing the most differential response. Approximately half of the donors increased 
expression of IL-17 in response to the wear debris, whilst half reduced expression.  
 Th17 cells, defined by their secretion of IL-17, play a crucial role in the initiation of 
inflammation, recruiting neutrophils and macrophages to sites of infection (29), or tissue damage 
in the case of sterile inflammation. It has become clear in recent years that aberrant regulation of 
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Th17 cells is involved in the pathogenesis of a range of chronic inflammatory conditions, 
including Rheumatoid Arthritis (30, 31). To determine whether the differential Th17 response, or 
the Th1 response which also showed a marked difference between donors, are associated with a 
poor response to a CoCrMo implant we will need to repeat the analysis in patients undergoing 
revision surgery for a failed implant. Equally, determining a mechanism of T cell activation, 
perhaps through interaction with macrophages as has previously been postulated (22) could be 
valuable for development of therapeutic tools for the management of patients who currently 
have a CoCrMo prosthesis. 
It is known that the immune system becomes differentially regulated with age causing immune 
senescence and changes in systemic inflammatory status. Discharge data from the US 
Department for Health & Human Services (HHS) show a 2.2 fold increase in THR operations 
for people aged 45-55 between 2000 and 2010 (32). Therefore, given this trend towards younger 
patients receiving THR, we investigated whether the ageing immune system had a differential 
response to wear debris. Analysis of a healthy young and healthy old cohort in this study 
revealed that the healthy old subjects had a reduced pro-inflammatory IL-6 response to CoCrMo 
wear debris whilst no other marker differed significantly with age. The overall reduction in the 
IL-6 response in the older cohort suggests that older patients may produce a less severe 
inflammatory response to CoCrMo wear debris than younger patients.  
Smith et al (2012) (1) identified that the failure rate of CoCrMo bearings was greater in females. 
There are possible anatomical and tribological reasons for this increased failure although 
differences in the immune response have not previously been investigated. To address this we 
analysed serum-cytokine levels in male and female patients. Females were found to have 
significantly increased levels of IL-10 following debris challenge. Although the anti-inflammatory 
nature of IL-10 could be thought of as being desirable, excess IL-10 is known to impair 
osteoclast formation and function (10, 12). This could lead to decreased bone remodelling 
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around the bone-bound surfaces of the implant and thus lead to loosening of the implant and 
subsequent accelerated failure over time. 
We have demonstrated here that T cells are activated in response to wear debris from CoCrMo 
alloys. Our experiments using whole blood carried out over 24h have allowed for initial 
macrophage processing of the debris followed by downstream activation of CD4+ T cells. This 
link was postulated by Hallab et al in 2010 (6) and although we are unable to show a direct 
relationship between macrophages and CD4+ T cells, the fact that T cells become activated 
suggests that macrophages may instigate this either through presentation of debris as antigen or 
cytokine secretion. CD4+ T cells do not have the capacity to respond to free debris thus 
suggesting upstream activation by another cell type.  
Particle analysis confirmed that debris within the size range currently considered to be 
immunologically relevant (1-10 μm) were present in the isolated debris fraction used in the 
biological response experiments where T cell pro- and anti-inflammatory cytokine repertoire was 
reported. However, the 1-10μm particles only made up just over 50% of the total number of 
debris particles in the sample with most of the remaining fraction sized between 400nm and 
1μm. The extent of the contribution from the sub-micron particles to the overall debris 
population was not evident at face value in the sizing data in its native volume% format. 
Furthermore, the prevalence of this 400nm-1μm fraction of particles made up 60% (by number) 
of the fluid obtained directly from the wear simulator (i.e. without any debris isolation post-
processing). This in turn raises an interesting question as to what extent (and in what manner) do 
sub-micron particles contribute to the immune response and bone homeostasis. While it has 
already been established that individual debris particles of the order of 400nm may be 
internalised via endocytosis and provoke an inflammatory response (32), one could speculate 
that these sub-micron particles could aggregate to illicit the same response as the larger debris 
particles. This could occur via two processed: i) sub-micron sized debris aggregates outside of 
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the cell triggering phagocytic uptake as with the solid micron scale debris or, ii) aggregation of 
sub-micron sized debris within the cell, potentially to the extent where they can no longer be 
transported to and/or processed by the lysosomes. A recent early report from within our group 
(33) suggested that the latter process occurs with ceramic particles in osteoblast-like cultures and 
an investigation into this effect with MoM debris will form part of our future work. 
This study does have limitations. The number of subjects used is relatively small, though it does 
support our original hypothesis that individuals show differential responses to wear debris. A 
much larger sample size will be needed however to define a distinct response profile and to 
confirm if this is related to the age and gender of the donor. The influences such as BMI should 
also be considered as these are known to influence the inflammatory status of an individual (33). 
The implants were wear tested under adverse conditions (subluxation), which explains the 
production of particles of 400nm or more in size while smaller particles are known to be 
produced under other wear conditions. While this wear condition alone may not fully represent 
the nature of the wear behind clinical cases, it does exclude the production of smaller particles 
from the surface and hence the findings from the immunological studies can be attributed to the 
micron scale particles with greater confidence. Additionally, this serves to highlight that correct 
positioning of the implant is of paramount importance. Finally, the CoCrMo debris from the 
wear simulator were generated in FCS and it is possible that FCS-derived proteins which make 
up the protein corona on the CoCrMo debris could contribute to the differential response to 
debris which we observe, however we have controlled for this by including 10% FCS in the 
control situation. It is possible that FCS proteins bound to the wear particles provide an element 
of immunogenicity, but pilot studies comparing PBS and 10% FCS effects on T cell populations 
found only modest effects on memory T cell subset distribution (decreased TEM and increased 
TEMRA, data not shown).  
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We have thus, for the first time, shown differential responses in individuals to wear debris from 
CoCrMo THR implants generated on a wear simulator.  We believe that we have identified 
potential candidate markers which could form the basis of future clinical trials to evaluate such 
differential cytokine expression along with other parameters - such as age and gender - in order 
to determine the prognostic value of each. 
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Table 1 Demographic data showing age and gender breakdown 
 
 
 
 
 
 
 
 
 
 
 
 
  
 n (%) Mean age ± SD 
(years) 
Young 16 (73%) 25.1 ± 4.27 
Old 6 (27%) 58.3 ± 8.43 
Male 10 (45%) 37.2 ± 16.9 
Female 12 (55%) 31.8 ± 16.6 
16 
 
Table 2 Contribution of wear-particle size classes of interest to the total number and volume 
of wear particles before and after the isolation procedure. 
 
Wear particle stock solution from wear 
simulator 
Wear particles isolated from stock 
solution 
Size range: 0.4μm-200μm 0.5μm-12μm* 
Size classes % by number % by volume % by number % by volume 
0.40μm-0.99μm 59.62 (±0.15) 0.98 (±0.01) 48.57 (±1.21) 1.58 (±0.10) 
1.00μm - 10μm 40.35 (±0.12) 44.81 (±0.33) 51.41 (±0.72) 72.13 (±0.42) 
>10um 0.02 (<<0.01) 54.20 (±0.60) 0.01 (<<0.01) 26.29 (±0.39) 
TOTAL 100 100 100 100 
* particles up to 60μm were detected, but not repeatable in consecutive measurement runs. 
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Figure Legends 
Figure 1: Size distribution of wear-particles in FCS taken from a hip-wear simulator (‘stock 
solution’) and of the wear-particles isolated from the stock solution. Distributions are shown in 
terms of contribution to total volume of wear-particles analysed (a) and the total number of 
wear-particles analysed (b). VM = volume weighted, SD = standard deviation. 
Figure 2: Scanning Electron Microscopy (SEM) images of the CoCrMo wear debris isolated 
from the bulk serum solution used during the wear simulation. The low magnification image (a) 
shows both the micron and the more prevalent sub-micron scale debris particles identified from 
the particle sizing data. The reduced contrast of the image relates to the serum protein coating 
around the particles, which would be the case for wear debris generated in vivo. The high 
magnification image (b) revealed the rounded morphology of the debris along with their 
propensity to aggregate without further sample processing.  
Figure 3: Whole blood from 22 donors was exposed to wear debris or 10% FCS for 24h and T 
cell populations identified by immunostaining and flow cytometry. The prevalence of different T 
cell populations, Th1, Th17, Treg and plastic Th17 are shown for control cells or cells challenged 
with CoCrMo. Each data point represents the response of an individual subject and the 
horizontal bar represents the median response. 
Figure 4: Data from figure 3 were re-plotted to show the response of individual subjects for the 
FCS control and CoCrMo exposure. For Th17 and Th1 there were marked differences and thus 
these data are shown as a pro- or anti-inflammatory response.  
Figure 5: Plasma levels of pro-inflammatory and anti-inflammatory cytokines in FCS control 
and CoCrMo exposed cells were measured using multiplex technology. Each data point 
represents the response of an individual subject and the bar indicates the median value and *** is 
p=<0.0001. 
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Figure 6: The response to CrCrMo debris was analysed with respect to (a) Gender for the IL-10 
response and (b)age for the IL-6 response. Each data point represents the response of an 
individual subject and the bar indicates the median value and actual p values are reported. 
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